176 related articles for article (PubMed ID: 19862873)
1. A review of the literature on topical therapies for diabetic foot ulcers. Part 2: Advanced treatments.
White R; McIntosh C
J Wound Care; 2009 Aug; 18(8):335-41. PubMed ID: 19862873
[TBL] [Abstract][Full Text] [Related]
2. Advanced biological therapies for diabetic foot ulcers.
Kirsner RS; Warriner R; Michela M; Stasik L; Freeman K
Arch Dermatol; 2010 Aug; 146(8):857-62. PubMed ID: 20713816
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.
Persson U; Willis M; Odegaard K; Apelqvist J
Value Health; 2000; 3 Suppl 1():39-46. PubMed ID: 16464208
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.
Sibbald RG; Torrance G; Hux M; Attard C; Milkovich N
Ostomy Wound Manage; 2003 Nov; 49(11):76-84. PubMed ID: 14652415
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.
Steed DL
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):143S-149S; discussion 150S-151S. PubMed ID: 16799381
[TBL] [Abstract][Full Text] [Related]
6. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
7. Cost-effective management of recalcitrant diabetic foot ulcers.
Albert S
Clin Podiatr Med Surg; 2002 Oct; 19(4):483-91. PubMed ID: 12471856
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic foot ulcers using a blood bank platelet concentrate.
Jeong SH; Han SK; Kim WK
Plast Reconstr Surg; 2010 Mar; 125(3):944-52. PubMed ID: 20195121
[TBL] [Abstract][Full Text] [Related]
9. Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer.
Lantis JC; Boone D; Gendics C; Todd G
Adv Skin Wound Care; 2009 Apr; 22(4):167-71. PubMed ID: 19325276
[TBL] [Abstract][Full Text] [Related]
10. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?
Papanas N; Maltezos E
Int J Low Extrem Wounds; 2007 Mar; 6(1):37-53. PubMed ID: 17344201
[TBL] [Abstract][Full Text] [Related]
11. Neovascularisation in wound healing.
Stavrou D
J Wound Care; 2008 Jul; 17(7):298-300, 302. PubMed ID: 18705231
[TBL] [Abstract][Full Text] [Related]
12. Split-skin graft in the management of diabetic foot ulcers.
Mahmoud SM; Mohamed AA; Mahdi SE; Ahmed ME
J Wound Care; 2008 Jul; 17(7):303-6. PubMed ID: 18705232
[TBL] [Abstract][Full Text] [Related]
13. [New developments in the treatment of diabetic foot ulcers].
Bakker K; Schaper NC
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):409-12. PubMed ID: 10719543
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers.
Fetterolf DE; Istwan NB; Stanziano GJ
Manag Care; 2014 Jul; 23(7):31-8. PubMed ID: 25199368
[No Abstract] [Full Text] [Related]
16. A randomised controlled trial on the effectiveness of an advanced wound dressing used in Iran.
Kordestani S; Shahrezaee M; Tahmasebi MN; Hajimahmodi H; Haji Ghasemali D; Abyaneh MS
J Wound Care; 2008 Jul; 17(7):323-7. PubMed ID: 18705234
[TBL] [Abstract][Full Text] [Related]
17. New treatments in ulcer healing and wound infection.
Edmonds M; Bates M; Doxford M; Gough A; Foster A
Diabetes Metab Res Rev; 2000; 16 Suppl 1():S51-4. PubMed ID: 11054889
[TBL] [Abstract][Full Text] [Related]
18. Topical and biologic therapies for diabetic foot ulcers.
Richmond NA; Vivas AC; Kirsner RS
Med Clin North Am; 2013 Sep; 97(5):883-98. PubMed ID: 23992899
[TBL] [Abstract][Full Text] [Related]
19. Using angiogenesis in chronic wound care with becaplermin and oxidized regenerated cellulose/collagen.
Hollister C; Li VW
Nurs Clin North Am; 2007 Sep; 42(3):457-65, vii. PubMed ID: 17825664
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diabetic ulcers.
Dinh TL; Veves A
Dermatol Ther; 2006; 19(6):348-55. PubMed ID: 17199677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
